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ABSTRACT: A concise formal synthesis of (±)-aspidospermidine via Stork’s intermediate, which could be used as a divergent 
synthesis of Aspidosperma alkaloids, was achieved by employing a ring-opening cyclization of spirocyclopropane with amine fol-
lowed by a regioselective intramolecular/intermolecular alkylation sequence. Stork’s intermediate was synthesized in only six steps 
from a simple starting material, 1,3-cyclohexanedione, and was converted into (±)-aspidospermidine. To the best of our knowledge, 
this synthesis of Stork’s intermediate involves the least number of steps to date. Furthermore, no protecting groups were used dur-
ing this synthesis. 
INTRODUCTION 
Over the past half-century, Aspidosperma alkaloids 1 (Fig-
ure 1) have elicited considerable attention from synthetic 
chemists due to their structural diversity and interesting bio-
logical activities.1 Aspidospermidine (1a) and aspidospermine 
(1b), the prototypical members of the group, contain a penta-
cyclic [6.5.6.6.5]-ABCDE ring system and have been attrac-
tive targets for demonstrating new synthetic approaches to 
Aspidosperma alkaloids.2 
 
 
 
Figure 1. Representative structures of Aspidosperma alkaloids 1. 
 
As a pioneering Aspidosperma alkaloid synthesis, Stork and 
Dolfini reported total synthesis of aspidospermine (1b) and 
quebrachamine (1d) in 1963, in which tricyclic [6.6.5]-CDE 
ring compound 2 was used as a key synthetic intermediate 
(Scheme 1A).3 CDE ring 2 was constructed from a starting 
material possessing the C ring by forming the D ring followed 
by the E ring.4 Conversion of 2 into natural products was 
achieved by using a Fischer indolization and reduction se-
quence, although the stereochemistry of 2 was not determined 
at this point.5 In 2000, Aubé and co-workers reported the total 
synthesis of (+)-aspidospermidine (1a) via intermediate 2 and 
established the stereochemistry of 2.6 Recently, Jiang and co-
workers demonstrated a divergent asymmetric synthesis of 
Aspidosperma alkaloids including (−)-pyrifolidine (1c) and 
()-vincadifformine (1e) from 2.7 Therefore, intermediate 2 
has become an attractive and well-known target as a Stork’s 
intermediate, and various synthetic approaches to 2 have been 
reported to date.8,9 
We previously reported a regioselective ring-opening cy-
clization of spirocyclopropanes 3 with primary amines 4 to 
generate 2-substituted tetrahydroindol-4-ones 5 (Scheme 
1B).10,11 Furthermore, regioselective alkylation of 5 at the C-7 
position to form alkylated product 6 was achieved by using 
lithium hexamethyldisilazide (LiHMDS) as a base.12 Based on 
these results, we envisioned that these reactions could be ap-
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plied to synthesize tricyclic CDE ring compound 2. Herein, we 
report a concise route to Aspidosperma alkaloid (±)-
aspidospermidine (1a) via Stork’s intermediate 2, employing a 
ring-opening cyclization of spirocyclopropane 3a with amine 
4 to construct CE ring system 5 followed by a regioselective 
intramolecular/intermolecular alkylation sequence to form the 
D ring (Scheme 1C). 
 
Scheme 1. Stork’s-Intermediate-based Approaches to As-
pidosperma Alkaloids 1 
 
 
RESULTS AND DISCUSSION 
Our synthetic strategy for Stork’s intermediate 2 is illustrat-
ed in Scheme 2. We planned to use 1,3-cyclohexanedione (7) 
as the C ring. After conversion of 7 into spirocyclopropane 3a 
by our synthetic method,13 construction of the E ring could be 
achieved through a ring-opening cyclization of spirocyclopro-
pane 3a with propylamine 4 to produce bicyclic product 5 
possessing a C3 unit at the nitrogen atom for constructing the 
D ring.10 We then devised two synthetic routes as follows. One 
was an intermolecular alkylation of 5 for introducing the ethyl 
group followed by intramolecular alkylation of resulting prod-
uct 6 to construct the D ring (route A). The other was to use 
the two alkylations in reverse order, such as an intramolecu-
lar/intermolecular alkylation sequence via tricyclic intermedi-
ate 8 (route B). Finally, reduction of the obtained tricyclic 
CDE ring system 9 would produce key intermediate 2. We 
predicted that the second alkylation step at the tertiary carbon 
could be more difficult due to the steric hindrance. Generally, 
an intramolecular reaction proceeds more easily than an inter-
molecular one. Therefore, we initially investigated an intermo-
lecular/intramolecular alkylation sequence (route A). 
 
 
 
 
Scheme 2. Synthetic Strategy for Stork’s Intermediate 2 
 
 
At the outset of this work, synthetic approach by route A 
starting from 1,3-cyclohexanedione (7) is shown in Scheme 3. 
The reaction of 7 with sulfonium salt 10 and powdered K2CO3 
in EtOAc provided spirocyclopropane 3a in 93% yield.13 
Ring-opening cyclization of 3a with tert-butyldimethylsilyl 
(TBS)-protected 3-amino-1-propanol 4a proceeded smoothly 
in THF at 50 °C to produce tetrahydroindol-4-one 5a in 96% 
yield. An intermolecular regioselective alkylation of 5a with 
ethyl iodide using LiHMDS as a base afforded ethylated prod-
uct 6a in 90% yield. After deprotection of TBS ether 6a with 
tetrabutylammonium fluoride (TBAF), halogenation of result-
ing alcohol 6b using N-halosuccinimide (NXS, X = I, Br) and 
triphenylphosphine gave the corresponding iodide 6c and 
bromide 6d in 84% and 55% yields, respectively. We then 
examined an intramolecular alkylation using halogenated al-
kanes 6c and 6d. When these were treated with LiHMDS as a 
base, cyclization did not proceed. A small amount of corre-
sponding alkene 11 (16%–31% yields) rather than tricyclic 
compound 9 was obtained by E2 elimination.  
 
Scheme 3. Synthetic Approach Using Regioselective In-
termolecular/Intramolecular Alkylations (Route A) 
 
 
Since the intermolecular/intramolecular alkylation sequence 
could not be used to synthesize tricyclic compound 9, we next 
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investigated an intramolecular/intermolecular alkylation se-
quence (route B, Scheme 4). To omit the deprotection step, we 
used 3-amino-1-propanol 4b for the ring-opening cyclization 
of 3a. The reaction proceeded uneventfully to provide tetrahy-
droindol-4-one 5b in 91% yield. In this key reaction, amino 
group, which is more nucleophilic than hydroxy group, in 4b 
would attack the cyclopropyl carbon in 3a to cleave the cyclo-
propane and the subsequent cyclization would form 5b.10 Hal-
ogenation of alcohol 5b using NXS and Ph3P gave correspond-
ing iodide 5c and bromide 5d. We then examined an intramo-
lecular alkylation of 5c and 5d using LiHMDS as a base. The 
use of iodide 5c afforded tricyclic product 8 in 56% yield, 
accompanied by a small amount of elimination product. When 
bromide 5d was used in this reaction, the yield of 8 increased 
to 74%. Gratifyingly, the reaction of 5d in the presence of 0.1 
equiv of tetrabutylammonium iodide (TBAI) increased the 
product yield to 86%. Intermolecular alkylation at the C-7 
tertiary carbon of 8 was achieved by using excess amount of 
alkylating reagent. The reaction of 8 with LiHMDS (1.1 
equiv) and ethyl iodide (5 equiv) gave ethylated product 98a,j in 
88% yield. 
 
Scheme 4. Synthetic Approach Using Regioselective In-
tramolecular/Intermolecular Alkylations (Route B) 
 
 
With tricyclic intermediate 9 in hand,8a,j we then investigat-
ed the reduction of 9 (Table 1). The use of lithium aluminum 
hydride (LiAlH4) as a reductant afforded 9b-epi-product 12 in 
81% yield (entry 1), as well as the previous reports.14 Addi-
tionally, the reaction under Birch reduction conditions also 
provided 12 in 54% yield (entry 2). We then examined the 
hydrogenation of 9.15 To our delight, the reaction of 9 with a 
catalytic amount of Pt/C in acetic acid under hydrogen at 
50 °C gave Stork’s intermediate 2 in 18% yield (entry 3). Syn-
thetic material 2 showed spectroscopic data (1H and 13C NMR, 
and IR) consistent with those reported for product 2.8a–c Be-
cause this Pt/C-catalyzed hydrogenation required a long reac-
tion time to reach completion (28 h), the product 2 was partial-
ly decomposed under the reaction conditions to cause the low 
yield of 2. After considerable screening of the reaction condi-
tions, we found that hydrogenation with a catalytic amount of 
Pd/C in acetic acid at 50 °C proceeded faster to completion 
within 12 h, affording 2 in 34% yield along with decomposi-
tion products (entry 6).16 Consequently, Stork’s intermediate 2 
was synthesized in only six steps from a simple starting mate-
rial, 1,3-cyclohexanedione (7), and no protecting groups were 
used during this route.  
 
Table 1. Stereoselective Reduction of Enaminone 9 
 
     yield (%)a 
entry reductant solvent temp. time (h) 2 12 
1 LiAlH4 THF reflux 0.5 – 81 
2 Na, liq. NH3 THF −78 °C to rt 2 – 54 
  3 Pt/C, H2 AcOH 50 °C 28 18 – 
  4 PtO2, H2 AcOH 50 °C 24 8 – 
  5 Pd(OH)2, H2 EtOAc 50 °C 13 14 – 
  6 Pd/C, H2 AcOH 50 °C 12 34 – 
  7 cat. Rh(I),b H2 toluene 50 °C 12 NRd 
  8 cat. Ir(I),c H2 CH2Cl2 rt 12 NRd 
aIsolated yield. bWilkinson’s catalyst. cCrabtree’s catalyst. dNo 
reaction. 
 
The synthesis of aspidospermidine (1a) from Stork’s inter-
mediate 2 by employing Fischer indolization with phenylhy-
drazine in acetic acid and subsequent reduction with LiAlH4 or 
NaBH4 was achieved by several research groups.17 We also 
demonstrated this conversion under the above conditions and 
obtained natural product 1a in 32% yield (Scheme 5).18 With 
the expectation that isomerization of the stereochemistry at C-
9b of 12 could proceed in the indolization step,19 conversion of 
12 into 1a was also explored. Unfortunately, this approach 
was unsuccessful, as in previous studies.20 
 
Scheme 5. Synthesis of Aspidospermidine (1a) 
 
 
CONCLUSION 
A concise formal synthesis of (±)-aspidospermidine via 
Stork’s intermediate was achieved by employing a ring-
opening cyclization of spirocyclopropane followed by a regi-
oselective intramolecular/intermolecular alkylation sequence. 
Stork’s intermediate, which could be converted into various 
Aspidosperma alkaloids, was synthesized in only six steps 
from a simple starting material, 1,3-cyclohexanedione, and 
was converted into (±)-aspidospermidine in two steps. To the 
best of our knowledge, this synthesis of Stork’s intermediate 
involves the least number of steps to date.21 Additionally, no 
protecting groups were used during this synthesis. Further 
efforts toward the asymmetric synthesis of (+)-
aspidospermidine and related alkaloids employing an enanti-
oselective intermolecular alkylation are currently in progress. 
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EXPERIMENTAL SECTION 
General. Melting points are uncorrected. IR spectra were recorded 
on a JASCO FT/IR-460 Plus spectrophotometer and absorbance 
bands are reported in wavenumber (cm−1). 1H NMR spectra were 
recorded on JEOL JNM-ECX400P (400 MHz) spectrometer. Chemi-
cal shifts are reported relative to internal standard (tetramethylsilane 
at H 0.00 or CDCl3 at H 7.26). Data are presented as follows: chemi-
cal shift (, ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, quint = quintet, m = multiplet, br = broad), coupling constant 
and integration. 13C{1H} NMR spectra were recorded on JEOL JNM-
ECX400P (100 MHz) spectrometer. The following internal reference 
was used (CDCl3 at  77.0). High-resolution mass spectra (HRMS) 
were recorded on JEOL JMS-GCmate II (EI) and JEOL JMS-
AX505HAD (FAB) double-focusing magnetic-sector mass spectrom-
eters. Column chromatography was performed on Silica Gel 60 PF254 
(Nacalai Tesque) and Kanto silica gel 60 N (63–210 mesh) under 
pressure. Analytical thin layer chromatography (TLC) was carried out 
on Merck Kieselgel 60 F254 plates. Visualization was accomplished 
with UV light and phosphomolybdic acid stain solution followed by 
heating. An oil bath was used for conventional heating. 
All reagents such as 1,3-cyclohexanedione (7), powdered potassium 
carbonate, 3-amino-1-propanol (4b), 1,1,1,3,3,3-hexamethyldisilazane 
(HMDS), ethyl iodide, N-iodosuccinimide (NIS), N-
bromosuccinimide (NBS), triphenylphosphine, tetrabutylammonium 
iodide (TBAI), phenylhydrazine, acetic acid, and lithium aluminum 
hydride are commercially available and were purchased from suppli-
ers such as Sigma-Aldrich Co.; Wako Pure Chemical Industries, Ltd.; 
Tokyo Chemical Industry Co., Ltd.; Nacalai Tesque, INC. Dehydrated 
CH2Cl2, THF, EtOAc, toluene, and benzene were purchased from 
Wako Pure Chemical Industries, Ltd. Sulfonium salt 1013 and 3-(tert-
butyldimethylsilyloxy)propylamine (4a)22 were prepared according to 
literature procedures. 
Preparation of LiHMDS (0.83 M in THF/hexane): BuLi (1.64 M in 
hexane, 6.1 mL, 10.0 mmol) was added to a solution of HMDS (2.3 
mL, 11.0 mmol) in THF (3.6 mL) at 0 C, and then the mixture was 
stirred at 0 C for 0.5 h. 
Intermolecular/intramolecular alkylation sequence (route A). 
Spiro[2.5]octane-4,8-dione (3a).13 Powdered K2CO3 (2.51 g, 18.2 
mmol) and 1,3-cyclohexanedione (7) (0.68 g, 6.06 mmol) were added 
to a suspension of sulfonium salt 10 (2.95 g, 6.67 mmol) in EtOAc 
(60 mL). After stirring at rt for 3 h, the reaction mixture was filtered 
through a pad of Celite. The filter cake was rinsed with EtOAc (30 
mL) and the filtrate was quenched with water (20 mL) and the whole 
mixture was extracted with EtOAc (2 × 10 mL). The combined organ-
ic layer was washed with water (20 mL), brine (20 mL) and dried 
over anhydrous MgSO4. The filtrate was concentrated in vacuo, and 
the residue was purified by column chromatography (silica gel, 40% 
EtOAc in hexane) to provide 3a (778 mg, 93%) as a pale yellow oil: 
IR (film, cm−1) ν 2956, 1682, 1330, 1162, 1026, 956; 1H NMR (400 
MHz, CDCl3) δ 2.67 (t, J = 6.4 Hz, 4H), 2.15 (quint, J = 6.4 Hz, 2H), 
1.76 (s, 4H); 13C{1H} NMR (100 MHz, CDCl3) δ 206.8, 40.6, 39.4, 
27.4, 17.9; HRMS (EI) m/z calcd for C8H10O2 (M+) 138.0681, found 
138.0668. 
1-(3-tert-Butyldimethylsilyloxy)propyl-2,3,6,7-tetrahydro-1H-indol-
4(5H)-one (5a). 3-(tert-Butyldimethylsilyloxy)propylamine (4a) (232 
mg, 1.23 mmol) was added to a solution of spirocyclopropane 3a (113 
mg, 0.82 mmol) in THF (1.6 mL). After stirring at 50 °C for 4.5 h, the 
reaction mixture was concentrated in vacuo, and the residue was puri-
fied by column chromatography (silica gel, 5% MeOH in CH2Cl2) to 
provide 5a (243 mg, 96%) as a yellow oil: IR (film, cm−1) 2918, 
2849, 1509, 1440, 1290, 1254, 1190, 1094; 1H NMR (400 MHz, 
CDCl3)  3.59 (t, J = 5.6 Hz, 2H), 3.50 (t, J = 9.8 Hz, 2H), 3.27 (t, J = 
7.0 Hz, 2H), 2.73 (t, J = 9.8 Hz, 2H), 2.32 (t, J = 6.2 Hz, 2H), 2.26 (t, 
J = 6.2 Hz, 2H), 1.94 (tt, J = 5.6, 7.0 Hz, 2H), 1.69 (quint, J = 6.2 Hz, 
2H), 0.86 (s, 9H), 0.02 (s, 6H); 13C{1H} NMR (100 MHz, CDCl3) 
190.6, 168.8, 108.9, 59.3, 51.3, 42.8, 35.6, 30.7, 25.8, 23.9, 22.5, 
22.3, 18.1, −5.5; HRMS (EI) m/z calcd for C17H31NO2Si (M+) 
309.2124, found 309.2127. 
1-(3-tert-Butyldimethylsilyloxy)propyl-7-ethyl-2,3,6,7-tetrahydro-
1H-indol-4(5H)-one (6a). A solution of LiHMDS (1.05 mL, 0.83 M 
in THF/hexane, 0.88 mmol) was added to a solution of 5a (246 mg, 
0.80 mmol) in THF (8 mL) at −78 C. After stirring at −78 C for 1 h, 
ethyl iodide (0.096 mL, 1.2 mmol) was added to the mixture and the 
whole was allowed to warm to room temperature over 1.5 h. The 
reaction mixture was quenched with saturated aqueous NH4Cl (10 
mL), and the whole mixture was extracted with CH2Cl2 (2 x 10 mL). 
The combined organic layers were washed with water (10 mL) and 
brine (10 mL), and dried over anhydrous MgSO4. Filtration and evap-
oration in vacuo furnished the crude product, which was purified by 
column chromatography (silica gel, 5% MeOH in CH2Cl2) to provide 
6a (268 mg, 90%) as a yellowish brown oil: IR (film, cm−1) 2929, 
2857, 2360, 2341, 1556, 1504, 1253, 1178, 1092, 836; 1H NMR (400 
MHz, CDCl3)  3.66–3.54 (m, 2H), 3.47 (td, J = 9.8, 2.4 Hz, 2H), 
3.33 (dt, J = 15.2, 7.6 Hz, 1H), 3.16 (dt, J = 15.2, 7.6 Hz, 1H), 2.72 (t, 
J = 9.8 Hz, 2H), 2.41–2.33 (m, 2H), 2.16 (dd, J = 17.6, 2.0 Hz, 1H), 
1.98 (dt, J = 13.6, 2.0 Hz, 1H), 1.87 (m, 1H), 1.73–1.71 (m, 2H), 
1.59–1.46 (m, 2H), 1.01 (t, J = 7.2 Hz, 3H), 0.87 (s, 9H), 0.32 (s, 6H); 
13C{1H} NMR (100 MHz, CDCl3) 190.2, 172.3, 107.8, 59.4, 50.8, 
42.9, 33.1, 31.4, 30.7, 25.8, 25.0, 23.9, 23.1, 18.2, 12.5, −5.5; HRMS 
(FAB) m/z calcd for C19H36NO2Si (M+H)+ 338.2515, found 338.2508. 
7-Ethyl-1-(3-hydroxy)propyl-2,3,6,7-tetrahydro-1H-indol-4(5H)-
one (6b). TBAF (1.16 mL, 1 M in THF, 1.16 mmol) was added to a 
solution of 6a (390 mg, 1.16 mmol) in THF (5.8 mL) at 0 °C. After 
stirring at room temperature for 0.5 h, the reaction mixture was con-
centrated in vacuo, and the residue was purified by column chroma-
tography (silica gel, 11% MeOH in CH2Cl2) to provide 6b (258 mg, 
quant.) as a yellowish brown oil: IR (film, cm−1) 3278, 2935, 2871, 
1579, 1534, 1507, 1446, 1299, 1198, 1181; 1H NMR (400 MHz, 
CDCl3)  3.73–3.63 (m, 2H), 3.57–3.40 (m, 4H), 3.28 (dt, J = 13.2, 
6.6 Hz, 1H), 2.73 (t, J = 9.6 Hz, 2H), 2.47 (dd, J = 4.8, 4.0 Hz, 1H), 
2.39 (ddd, J = 17.8, 14.0, 4.0 Hz, 2H), 2.16 (dd, J = 17.8, 3.2 Hz, 2H), 
2.02 (dt, J = 13.2, 2.4 Hz, 1H), 1.93 (dt, J = 14.0, 4.8 Hz, 1H), 1.84 
(td, J = 12.8, 6.6 Hz, 2H), 1.59–1.49 (m, 2H), 1.04 (t, J = 7.2 Hz, 3H); 
13C{1H} NMR (100 MHz, CDCl3) 190.0, 173.3, 107.7, 58.9, 50.9, 
43.1, 33.2, 31.1, 30.4, 24.9, 23.6, 23.1, 12.5; HRMS (EI) m/z calcd for 
C13H21NO2 (M+) 223.1572, found 223.1573. 
Typical procedure for halogenation of alcohols. 7-Ethyl-1-(3-
iodo)propyl-2,3,6,7-tetrahydro-1H-indol-4(5H)-one (6c). NIS (170 
mg, 0.65 mmol) and triphenylphosphine (146 mg, 0.65 mmol) were 
added to a solution of 6b (97 mg, 0.43 mmol) in CH2Cl2 (2.2 mL). 
After stirring at room temperature for 0.5 h, the reaction mixture was 
concentrated in vacuo, and the residue was purified by column chro-
matography (silica gel, 5% MeOH in CH2Cl2) to provide 6c (122 mg, 
84%) as a yellowish brown oil: IR (film, cm−1) 2934, 2870, 1581, 
1542, 1503, 1445, 1299, 1248, 1195, 1181; 1H NMR (400 MHz, 
CDCl3)  3.48 (td, J = 9.6, 2.0 Hz, 2H), 3.39–3.14 (m, 4H), 2.75 (t, J 
= 9.6 Hz, 2H), 2.47–2.36 (m, 2H), 2.21 (ddd, J = 17.2, 5.0, 2.0 Hz, 
1H), 2.11–2.03 (m, 3H), 1.96 (tt, J = 13.6, 5.0 Hz, 1H), 1.66–1.45 (m, 
2H), 1.08 (t, J = 7.6 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl3) 
190.8, 171.9, 108.7, 51.1, 46.8, 33.5, 31.5, 31.1, 25.0, 24.0, 23.3, 
12.6, 2.1; HRMS (FAB) m/z calcd for C13H21INO (M+H)+ 334.0668, 
found 334.0676. 
1-(3-Bromo)propyl-7-ethyl-2,3,6,7-tetrahydro-1H-indol-4(5H)-one 
(6d). According to the typical procedure for halogenation of alcohols, 
bromide 6d was prepared from 6b (138 mg, 0.62 mmol), NBS (100 
mg, 0.93 mmol), and triphenylphosphine (243 mg, 0.93 mmol). The 
crude product was purified by column chromatography (silica gel, 5% 
MeOH in CH2Cl2) to provide 6d (98 mg, 55%) as a yellowish brown 
oil: IR (film, cm−1) 2936, 2871, 1581, 1542, 1504, 1446, 1300, 1261, 
1197, 1181; 1H NMR (400 MHz, CDCl3)  3.52–3.29 (m, 6H), 2.74 (t, 
J = 9.6 Hz, 2H), 2.47–2.36 (m, 2H), 2.23–2.03 (m, 4H), 1.96 (m, 1H), 
1.64–1.50 (m, 2H), 1.07 (t, J = 7.6 Hz, 3H); 13C{1H} NMR (100 MHz, 
CDCl3) 190.7, 172.1, 108.5, 50.9, 44.5, 33.3, 31.3, 30.3, 29.9, 24.9, 
23.9, 23.2, 12.5; HRMS (EI) m/z calcd for C13H20BrNO (M+) 
285.0728, found 285.0714. 
1-Allyl-7-ethyl-2,3,6,7-tetrahydro-1H-indol-4(5H)-one (11). A so-
lution of LiHMDS (0.21 mL, 0.83 M in THF/hexane, 0.17 mmol) was 
added to a solution of 6c (52 mg, 0.16 mmol) in THF (1.6 mL) at −78 
C. After stirring at −78 C for 1 h, the reaction mixture was allowed 
to warm to room temperature over 1.5 h. The reaction mixture was 
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quenched with saturated aqueous NH4Cl (5 mL), and the whole mix-
ture was extracted with CH2Cl2 (2 x 5 mL). The combined organic 
layers were washed with water (5 mL) and brine (5 mL), and dried 
over anhydrous MgSO4. Filtration and evaporation in vacuo furnished 
the crude product, which was purified by column chromatography 
(silica gel, 5% MeOH in CH2Cl2) to provide 11 (5.7 mg, 16%) as a 
brown oil: IR (film, cm−1) 2937, 2866, 1601, 1554, 1496, 1444, 
1352, 1298, 1244, 1173, 946, 908; 1H NMR (400 MHz, CDCl3)  
5.78 (m, 1H), 5.25 (dd, J = 10.4, 2.4 Hz, 1H), 5.21 (dd, J = 17.2, 2.4 
Hz, 1H), 3.80 (d, J = 5.0 Hz, 2H), 3.58–3.43 (m, 2H), 2.78–2.72 (m, 
2H), 2.43–2.35 (m, 2H), 2.20 (m, 1H), 2.05 (dt, J = 13.6, 3.2 Hz, 1H), 
1.95 (tt, J = 13.6, 5.0 Hz, 1H), 1.69–1.49 (m, 2H), 1.05 (t, J = 7.6 Hz, 
3H); 13C{1H} NMR (100 MHz, CDCl3) 190.5, 171.7, 132.4, 117.7, 
108.4, 51.0, 48.7, 33.3, 31.3, 25.0, 23.8, 23.2, 12.4; HRMS (FAB) m/z 
calcd for C13H20NO (M+H)+ 206.1545, found 206.1541. 
Intramolecular/intermolecular alkylation sequence (route B). 1-
(3-Hydroxy)propyl-2,3,6,7-tetrahydro-1H-indol-4(5H)-one (5b). 3-
Amino-1-propanol (4b) (535 mg, 7.12 mmol) was added to a solution 
of spirocyclopropane 3a (492 mg, 3.56 mmol) in THF (7 mL). After 
stirring at 50 °C for 2.5 h, the reaction mixture was concentrated in 
vacuo, and the residue was purified by column chromatography (silica 
gel, 11% MeOH in CH2Cl2) to provide 5b (630 mg, 91%) as a pale 
yellow solid: mp 80–81 °C; IR (KBr, cm–1) 3398, 2939, 2869, 1585, 
1535, 1511, 1439, 1290, 1190; 1H NMR (400 MHz, CDCl3)  3.96 (s, 
1H), 3.65 (t, J = 6.4 Hz, 2H), 3.57 (t, J = 9.6 Hz, 2H), 3.37 (t, J = 6.4 
Hz, 2H), 2.75 (t, J = 9.6, 2H), 2.39 (t, J = 6.2 Hz, 2H), 2.27 (t, J = 6.2 
Hz, 2H), 1.97 (quint, J = 6.4 Hz, 2H), 1.80 (quint, J = 6.2 Hz, 2H); 
13C{1H} NMR (100 MHz, CDCl3) 190.5, 169.6, 108.6, 58.7, 51.4, 
43.1, 35.4, 30.4, 23.8, 22.5, 22.1; HRMS (FAB) m/z calcd for 
C11H18NO2 (M+H)+ 196.1338, found 196.1337. 
1-(3-Iodo)propyl-2,3,6,7-tetrahydro-1H-indol-4(5H)-one (5c). Ac-
cording to the typical procedure for halogenation of alcohols, iodide 
5c was prepared from 5b (100 mg, 0.51 mmol), NIS (201 mg, 0.77 
mmol), and triphenylphosphine (173 mg, 0.77 mmol) at 0 °C for 0.5 h. 
The crude product was purified by column chromatography (silica gel, 
5% MeOH in CH2Cl2) to provide 5c (150 mg, 96%) as a brown oil: IR 
(film, cm−1) 2936, 2862, 1594, 1556, 1506, 1187; 1H NMR (400 
MHz, CDCl3)  3.51 (t, J = 9.6 Hz, 2H), 3.31 (t, J = 6.6 Hz, 2H), 3.19 
(t, J = 6.6 Hz, 2H), 2.78 (t, J = 9.6 Hz, 2H), 2.40 (t, J = 6.2 Hz, 2H), 
2.32 (t, J = 6.2 Hz, 2H), 2.10–1.99 (m, 4H); 13C{1H} NMR (100 MHz, 
CDCl3) 191.2, 168.4, 109.7, 51.5, 46.6, 35.7, 31.0, 24.1, 22.9, 22.2, 
2.3; HRMS (EI) m/z calcd for C11H16INO (M+) 305.0277, found 
305.0284. 
1-(3-Bromo)propyl-2,3,6,7-tetrahydro-1H-indol-4(5H)-one (5d). 
According to the typical procedure for halogenation of alcohols, bro-
mide 5d was prepared from 5b (1.05 g, 5.35 mmol), NBS (1.43 g, 
8.03 mmol), and triphenylphosphine (2.11 g, 8.03 mmol) at 0 °C for 
0.5 h. The crude product was purified by column chromatography 
(silica gel, 5% MeOH in CH2Cl2) to provide 5d (1.27 g, 93%) as a 
yellowish brown oil: IR (film, cm−1) 2941, 2868, 1581, 1542, 1508, 
1438, 1190; 1H NMR (400 MHz, CDCl3)  3.52 (t, J = 9.6 Hz, 2H), 
3.44 (t, J = 6.4 Hz, 2H), 3.38 (t, J = 6.4 Hz, 2H), 2.77 (t, J = 9.6 Hz, 
2H), 2.39 (t, J = 6.4 Hz, 2H), 2.30 (t, J = 6.4 Hz, 2H), 2.11 (quint, J = 
6.4 Hz, 2H), 2.01 (quint, J = 6.4 Hz, 2H); 13C{1H} NMR (100 MHz, 
CDCl3) 191.2, 168.4, 109.6, 51.4, 44.4, 35.7, 30.3, 30.0, 24.0, 22.6, 
22.2; HRMS (FAB) m/z calcd for C11H17BrNO (M+H)+ 258.0494, 
found 258.0496. 
1,2,4,5,6,6a,7,8-Octahydro-9H-pyrrolo[3,2,1-ij]quinolin-9-one (8). 
A solution of LiHMDS (11.9 mL, 0.83 M in THF/hexane, 9.87 mmol) 
was added to a solution of 5d (1.27 g, 4.93 mmol) and TBAI (182 mg, 
0.49 mmol) in THF (49 mL) at −78 C. After stirring at −78 C for 1 
h, the reaction mixture was allowed to warm to room temperature 
over 1.5 h. The reaction mixture was quenched with saturated aque-
ous NH4Cl (10 mL), and the whole mixture was extracted with 
CH2Cl2 (2 x 10 mL). The combined organic layers were washed with 
water (10 mL) and brine (10 mL), and dried over anhydrous MgSO4. 
Filtration and evaporation in vacuo furnished the crude product, 
which was purified by column chromatography (silica gel, 5% MeOH 
in CH2Cl2) to provide 8 (753 mg, 86%) as a pale yellow solid: mp 62–
63 °C; IR (KBr, cm−1) 2936, 2860, 1550, 1524, 1436, 1361, 1294, 
1196; 1H NMR (400 MHz, CDCl3)  3.62 (td, J = 10.8, 4.0 Hz, 1H), 
3.32–3.24 (m, 2H), 2.86 (td, J = 12.0, 4.0 Hz, 1H), 2.80 (td, J = 12.0, 
4.0 Hz, 1H), 2.68 (dtd, J = 14.8, 11.2, 2.0 Hz, 1H), 2.41–2.34 (m, 3H), 
2.01–1.94 (m, 3H), 1.85 (m, 1H), 1.61 (tt, J = 12.0, 9.4 Hz, 1H), 1.17 
(m, 1H); 13C{1H} NMR (100 MHz, CDCl3) 190.8, 169.5, 107.8, 
53.4, 46.3, 37.0, 33.4, 29.9, 26.7, 24.0, 22.8; HRMS (EI) m/z calcd for 
C11H15NO (M+) 177.1154, found 177.1147. 
6a-Ethyl-1,2,4,5,6,6a,7,8-octahydro-9H-pyrrolo[3,2,1-ij]quinolin-
9-one (9).8a,j A solution of LiHMDS (0.88 mL, 0.83 M in THF/hexane, 
0.73 mmol) was added to a solution of 8 (120 mg, 0.67 mmol) in THF 
(6.7 mL) at −78 C. After stirring at −78 C for 1 h, ethyl iodide (0.27 
mL, 3.35 mmol) was added to the mixture and the whole was allowed 
to warm to room temperature over 1.5 h. The reaction mixture was 
quenched with saturated aqueous NH4Cl (5 mL), and the whole mix-
ture was extracted with CH2Cl2 (2 x 5 mL). The combined organic 
layers were washed with water (5 mL) and brine (5 mL), and dried 
over anhydrous MgSO4. Filtration and evaporation in vacuo furnished 
the crude product, which was purified by column chromatography 
(silica gel, 5% MeOH in CH2Cl2) to provide 9 (123 mg, 88%) as a 
pale yellow solid: mp 63–64 °C; IR (KBr, cm−1) 2940, 2860, 1551, 
1522, 1463, 1439, 1355, 1302, 1267, 1192; 1H NMR (400 MHz, 
CDCl3)  3.60 (ddd, J = 11.2, 10.4, 3.6 Hz, 1H), 3.30 (dd, J = 11.2, 
5.2 Hz, 1H), 3.17 (q, J = 10.4 Hz, 1H), 2.85–2.74 (m, 2H), 2.62 (dt, J 
= 14.8, 11.2 Hz, 1H), 2.44 (ddd, J = 17.6, 13.2, 2.8 Hz, 1H), 2.27 (ddd, 
J = 17.6, 5.2, 2.4 Hz, 1H), 1.99 (dd, J = 4.4, 2.0 Hz, 1H), 1.96 (dd, J = 
5.2, 2.0 Hz, 1H), 1.90 (dt, J = 13.4, 3.2 Hz, 1H), 1.79 (m, 1H), 1.71–
1.63 (m, 2H), 1.55 (tdd, J = 13.4, 5.2, 1.2 Hz, 1H), 1.13 (td, J = 13.2, 
3.6 Hz, 1H), 0.89 (t, J = 7.6 Hz, 3H); 13C{1H} NMR (100 MHz, 
CDCl3) 190.1, 174.8, 107.7, 53.9, 47.2, 35.0, 33.6, 32.5, 28.7, 25.2, 
24.1, 18.7, 7.8; HRMS (FAB) m/z calcd for C13H20NO (M+H)+ 
206.1545, found 206.1542. 
Synthesis of (±)-aspidospermidine (1a). rac-(6aR,9aR,9bS)-6a-
Ethyldecahydro-4H-pyrrolo[3,2,1-ij]quinolin-9-one (2).6–8 10% Pd/C 
(82 mg, 200 wt% of 9) was added to a solution of 9 (41 mg, 0.2 
mmol) in AcOH (4 mL). The reaction mixture was vigorously stirred 
under H2 atmosphere at 50 C for 12 h. The mixture was filtered 
through a pad of Celite and the filter cake was rinsed with CH2Cl2 (20 
mL). The filtrate was concentrated in vacuo, and saturated aqueous 
NaHCO3 (20 mL) was added to the residue. The whole mixture was 
extracted with CH2Cl2 (2 × 10 mL), and the combined organic layer 
was washed with brine (10 mL) and dried over anhydrous MgSO4. 
The filtrate was concentrated in vacuo, and the residue was purified 
by column chromatography (silica gel, 1% MeOH in CHCl3) to pro-
vide 2 (14 mg, 34%) as a colorless oil: IR (film, cm−1) 2929, 1711, 
1457; 1H NMR (400 MHz, CDCl3)  3.03–2.99 (m, 2H), 2.67 (ddd, J 
= 9.0, 4.8, 1.6 Hz, 1H), 2.45–2.17 (m, 3H), 1.97–1.60 (m, 7H), 1.51–
1.47 (m, 2H), 1.37–1.28 (m, 2H), 1.10 (td, J = 13.4, 4.8 Hz, 1H), 0.94 
(t, J = 7.6 Hz, 3H); 13C{1H} NMR (100 MHz, CDCl3) 211.5, 73.6, 
53.2, 52.9, 48.2, 36.8, 34.8, 32.9, 30.1, 29.7, 26.1, 21.3, 7.1; HRMS 
(EI) m/z calcd for C13H21NO (M+) 207.1623, found 207.1616. 
(±)-Aspidospermidine (1a).6b According to the procedure of Aubé 
et al., we demonstrated conversion of 2 into aspidospermidine (1a). 
Phenylhydrazine (3.8 mg, 0.035 mmol) was added to a solution of 2 
(6.0 mg, 0.029 mmol) in benzene (0.83 mL). After stirring at reflux 
for 3 h, the reaction mixture was concentrated in vacuo, and the resi-
due was dissolved in AcOH (0.83 mL). After stirring at reflux for 3.5 
h, the reaction mixture was concentrated in vacuo, and the residue 
was dissolved in THF (0.83 mL). LiAlH4 (11 mg, 0.29 mmol) was 
added to a solution of the crude product at 0 C, and the reaction mix-
ture was stirred at reflux for 11 h. After cooling to 0 C, the reaction 
mixture was quenched by addition of one drop of aqueous 10% NaOH. 
The mixture was filtered through a pad of Celite and the filter cake 
was rinsed with CH2Cl2 (10 mL). The filtrate was concentrated in 
vacuo, and the residue was purified by column chromatography (silica 
gel, 11% MeOH in EtOAc) to provide 1a (2.6 mg, 32%) as a colorless 
oil: 1H NMR (400 MHz, CDCl3)  7.07 (d, J = 8.0 Hz, 1H), 7.02 (t, J 
= 7.2 Hz, 1H), 6.73 (t, J = 7.2 Hz, 1H), 6.64 (d, J = 8.0 Hz, 1H), 3.52 
(m, 1H), 3.12–3.06 (m, 2H), 2.35–2.20 (m, 3H), 1.98–1.91 (m, 2H), 
1.79–1.66 (m, 3H), 1.53–1.34 (m, 4H), 1.13 (m, 1H), 1.07 (m, 1H), 
 6
0.87 (m, 1H), 0.64 (t, J = 7.6 Hz, 3H). 1H NMR spectroscopic data 
corresponded to that quoted in ref. 6b. 
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